CXCL12 and glioblastoma: Kioi et al. have recently shown that the administration of AMD3100, an inhibitor of the SDF-1/CXCR4 interaction, blocked the recurrence of U251 GBM in nude mice after RT [19] by preventing the recruitment of radiation-induced BMDCs and by inhibiting vasculogenesis.